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3. THEORETICAL BASIS
ASD patient
• The exact GM profile in 
ASD is unclear
Mechanism of action?
Best time of administration?
Best composition?
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• Other approaches are 
needed.
N E W D I R E C T I O N S
PROBIOTICS’ 
UTILITY FOR ASD 
PREVENTION
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study
Fig 1: Main ASD-related microorganisms and their role in the disorder. PPA: Propionic Acid; CNS: Central Nervous System. Created with Biorender.
Fig 3: Major characteristics of probiotics use in ASD-rodent model: composition, moment of administration and 
principal outcomes. MHDF maternal high fat diet: ; MIA: Maternal Immune Activation; Created with Biorender.
Fig 4: Major characteristics of probiotics use in humans: composition, moment of administration, principal
outcomes and foremost limitations. GI: Gastrointestinall. Created with Biorender.
Autism Spectrum Disorder (ASD) is a neurodevelopmental
disorder that affects both behaviour and social
communication, alterations that are often combined with
other comorbidities, such as gastrointestinal dysfunction.
Bearing in mind the role of gut microbiota (GM) in the
correct Central Nervous System development and
function, it has been postulated that gastrointestinal
dysbiosis, which commonly affects ASD patients, is
involved in this disorder’s aetiology. For this reason, using
probiotics to restore the gastrointestinal equilibrium
could be a good therapeutic strategy for this disease.
• To know the characteristic GM profile of ASD patients.
• To give a comprehensive vision of the current state of
knowledge about the probiotics’ role in ASD from both
preclinical and clinical studies.
• To expose an exhaustive perspective of the near future
(clinical trials already registered) of this research field.
• To suggest new approaches and future study directions.
1. INTRODUCTION
2. AIMS
Fig 5: Future directions of probiotics in ASD research. 
BA: Butyric Acid. Created with Biorender.
6. CONCLUSIONS 7. FUTURE DIRECTIONS
4. METHODOLOGY
Fig 2: Methodology design of the systematic review, based on PRISMA protocol; DB: Databases; Created with Biorender.
Evidence from Animal Studies (n=7) Evidence from Human Studies (n=11)
5. RESULTS
Main idea: Findings from animal research are promising
Main idea: Evidence from human research is limited
• Probiotics in ASD is a 
booming domain of research.
Main conclusion: The current knowledge is promising but not enough to conclude 
that probiotics are effective on improving behavioural/GI ASD-related symptoms 
TOO MANY STUDY 
LIMITATIONS
Beneficial (↓)
Harmful (↑)
2-16 
years old
- Prospective studies : n=9
- Retrospective studies: n=2
I M P R O V E M E N T S
GM REDUCED
GM INCREASED
No severe 
adverse effects
Lactobacillus and Bifidobacterium
→ “Gold Standard” genus
Published human studies
• Little is known about how
to treat with probiotics
Partially solved in 
ongoing clinical trials
